Multiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what's new?

被引：0
|
作者：
Aljitawi, Omar S. [1 ]
McGuirk, Joseph P. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Blood & Marrow Transplant Program, Kansas City, KS 66103 USA
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2012年 / 1卷 / 01期
关键词：
autologous; chemotherapy; multiple myeloma; preparative regimen; review; transplant; STEM-CELL TRANSPLANTATION; CONDITIONING REGIMEN; PHASE-II; RANDOMIZED-TRIAL; ALLOGENEIC TRANSPLANTATION; INTERGROUPE FRANCOPHONE; STANDARD CHEMOTHERAPY; 200 MG/M(2); MELPHALAN; CYCLOPHOSPHAMIDE;
D O I：
10.2217/CER.11.11
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
High-dose chemotherapy and autologous stem cell transplantation remains a standard procedure in relatively young and selected older patients with multiple myeloma. High-dose melphalan has remained the chemotherapeutic agent of choice based on earlier prospective randomized trials. Despite investigations involving different combinations of chemotherapeutics, radiation and novel agents with and without melphalan, none of these alternative preparative regimens have demonstrated superiority to high-dose melphalan used as a single agent in multiple published studies. In this article, we review the published literature regarding preparative regimens used in patients with multiple myeloma undergoing autologous stem cell transplantation.
引用
收藏
页码：57 / 70
页数：14
相关论文
共 50 条
  • [1] High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
    Benson, Don M., Jr.
    Elder, Patrick J.
    Lin, Thomas S.
    Blum, William
    Penza, Sam
    Avalos, Belinda
    Copelan, Edward
    Farag, Sherif S.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1069 - 1075
  • [2] Velcade and high-dose melphalan: a new preparative regimen before autologous stem cell transplantation for multiple myeloma
    Danho, C
    Huynh, A
    Roussel, M
    Ysebaert, L
    Recher, C
    Huguet, FR
    Nouvel, C
    Laurent, G
    Attal, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S137 - S137
  • [3] High dose chemotherapy and autologous stem cell transplantation in multiple myeloma: Comparison of four preparative regimens.
    Alessandrino, EP
    Bragotti, LZ
    Colombo, AA
    Algarotti, A
    Bernasconi, P
    Maffioli, M
    Caldera, D
    Corso, A
    Rumi, E
    Troletti, D
    Lazzarino, M
    BLOOD, 2005, 106 (11) : 460B - 460B
  • [4] High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma
    Koh, LP
    Linn, YC
    Teoh, G
    Goh, YT
    Tan, PHC
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2002, 31 (06) : 731 - 737
  • [5] High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
    S Kumar
    M Q Lacy
    A Dispenzieri
    S V Rajkumar
    R Fonseca
    S Geyer
    C Allmer
    T E Witzig
    J A Lust
    P R Greipp
    R A Kyle
    M R Litzow
    M A Gertz
    Bone Marrow Transplantation, 2004, 34 : 161 - 167
  • [6] High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
    Kumar, S
    Lacy, MQ
    Dispenzieri, A
    Rajkumar, SV
    Fonseca, R
    Geyer, S
    Allmer, C
    Witzig, TE
    Lust, JA
    Greipp, PR
    Kyle, RA
    Litzow, MR
    Gertz, MA
    BONE MARROW TRANSPLANTATION, 2004, 34 (02) : 161 - 167
  • [7] Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma
    Cohen, Inbar
    Vaxman, Iuliana
    Gertz, Morie A.
    ACTA HAEMATOLOGICA, 2024,
  • [8] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
    Bernasconi, P
    Alessandrino, EP
    Colombo, AA
    Caldera, D
    Bonfichi, M
    Martinelli, G
    Malcovati, L
    Varettoni, M
    Maiocchi, M
    Brusamolino, E
    Pagnucco, G
    Castagnola, C
    Corso, A
    Bernasconi, C
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
  • [9] Arsenic trioxide with ascorbic acid and high-dose melphalan: A new preparative regimen for autologous hematopoietic stem cell transplantation for multiple myeloma.
    Qazilbash, MH
    Davis, MS
    Ana, A
    Roden, L
    Libunao, F
    Tball, PF
    Wang, XM
    Couriel, D
    De Lima, M
    Hosing, C
    Kebriaei, P
    Weber, D
    Wang, M
    Jones, RB
    Matthes, SG
    Champlin, RE
    Giralt, SA
    BLOOD, 2005, 106 (11) : 338A - 339A
  • [10] High-dose chemotherapy with treosulfan and melphalan before autologous transplantation in multiple myeloma
    Gillich, C.
    Jeker, B.
    Aebi, Y.
    Largiader, C.
    Hayoz, M.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 21 - 21
12345